Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sulodexide effects on venous endothelium in chronic venous insufficiency
2016-000783-42Phase 3Completed
- Sponsor
- Alfasigma Polska
- Start
- Jul 2016
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of sulodexide in venous stasis, sponsored by Alfasigma Polska. Primary endpoints: Change in inflammation, endothelial, glycocalyx, and fibrinolysis biomarkers and Effect of collected serum on HUVEC cells. Started Jul 2016; status: completed.
02
Drugs
sulodexide
03
Conditions
venous stasis
Beyond the preview
Go deeper on 2016-000783-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000783-42.